Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
By A Mystery Man Writer
Description
Advances in sequencing technology have made multigene testing, or “panel testing,” a practical option when looking for genetic variants that may be associated with a risk of breast cancer. In June
![Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk](https://www.npwomenshealthcare.com/wp-content/uploads/2022/05/BRCA-gene.jpg)
Position Statement: Hereditary Breast and Ovarian Cancer Risk Assessment - Women's Healthcare
![Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12885-019-5756-4/MediaObjects/12885_2019_5756_Fig1_HTML.png)
Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations, BMC Cancer
![Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10549-021-06441-y/MediaObjects/10549_2021_6441_Fig5_HTML.png)
A catalog of curated breast cancer genes
![Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13053-022-00232-2/MediaObjects/13053_2022_232_Fig1_HTML.png)
Spectrum of germline pathogenic variants using a targeted next generation sequencing panel and genotype-phenotype correlations in patients with suspected hereditary breast cancer at an academic medical centre in Pakistan
![Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk](https://www.frontiersin.org/files/Articles/602523/fonc-11-602523-HTML/image_m/fonc-11-602523-g001.jpg)
Frontiers Case Report: Detection of a Novel Germline PALB2 Deletion in a Young Woman With Hereditary Breast Cancer: When the Patient's Phenotype History Doesn't Lie
![Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk](https://becarispublishing.com/cms/10.2217/cer-2020-0192/asset/5c8758ce-788b-455c-ac3a-0ebaf06bc80b/assets/images/large/figure3.jpg)
Economic impact of multigene panel testing for hereditary breast and ovarian cancer
![Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2021/nejm_2021.384.issue-5/nejmoa2005936/20210131/images/img_medium/nejmoa2005936_t3.jpeg)
A Population-Based Study of Genes Previously Implicated in Breast Cancer
![Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk](https://www.medrxiv.org/content/medrxiv/early/2021/08/23/2021.08.13.21262050/F2.large.jpg)
Genetic assessments of breast cancer risk that do not account for polygenic background are incomplete and lead to incorrect preventative strategies
![Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk](https://www.cancerbiomed.org/sites/default/files/highwire/cbm/19/6.cover-source.jpg)
The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
![Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-018-06581-8/MediaObjects/41467_2018_6581_Fig1_HTML.png)
Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls
from
per adult (price varies by group size)